Terbinafine Related Compound C CAS 877265-30-0

• VIP4年
• GLP Pharma Standards
• 877265-30-0 NLT 95%
• Inquiry
• 2026-04-03

• VIP0年
• GLP Pharma Standards
• 877265-30-0 NLT 95%
• Inquiry
• 2026-04-03

• VIP4年
• GLP Pharma Standards
• Terbinafine EP Impurity A/ Terbinafine USP Related Compound A NLT 95%
• Inquiry
• 2026-04-03

• VIP0年
• GLP Pharma Standards
• Terbinafine EP Impurity A/ Terbinafine USP Related Compound A NLT 95%
• Inquiry
• 2026-04-03

• VIP4年
• GLP Pharma Standards
• Terbinafine EP Impurity D/ Terbinafine USP Related Compound D NLT 95%
• Inquiry
• 2026-04-03

• VIP0年
• GLP Pharma Standards
• Terbinafine EP Impurity D/ Terbinafine USP Related Compound D NLT 95%
• Inquiry
• 2026-04-03

• VIP4年
• GLP Pharma Standards
• Losartan Impurity-J (acetyleted compound)/Losartan USP Related Compound B / O-Acetyl Losartan / Losartan Acetate NLT 95%
• Inquiry
• 2026-04-02

• VIP0年
• GLP Pharma Standards
• Losartan Impurity-J (acetyleted compound)/Losartan USP Related Compound B / O-Acetyl Losartan / Losartan Acetate NLT 95%
• Inquiry
• 2026-04-02